Therapeutic potential of selective estrogen receptor modulators

Current Opinion in Chemical Biology

Volumn 2, Issue 4, 1998, Pages 508-511

  Gustafsson, Jan Åke ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ESTROGEN RECEPTOR; IPRIFLAVONE; ISOFLAVONE DERIVATIVE; PIPERIDINE DERIVATIVE; RALOXIFENE; TRANSCRIPTION FACTOR AP 1;

ANIMAL; CHEMISTRY; CLINICAL TRIAL; DNA RESPONSIVE ELEMENT; DRUG ANTAGONISM; DRUG DESIGN; DRUG POTENTIATION; GENETICS; HUMAN; METABOLISM; REVIEW;

ANIMALS; CLINICAL TRIALS; DRUG DESIGN; ESTROGEN ANTAGONISTS; HUMANS; ISOFLAVONES; PIPERIDINES; RALOXIFENE; RECEPTORS, ESTROGEN; RESPONSE ELEMENTS; TRANSCRIPTION FACTOR AP-1;

EID: 0032134252     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1367-5931(98)80127-0     Document Type: Article

References (27)

1. Mitlak BH, Cohen FJ: In search of optimal long-term female hormone replacement: the potential of selective estrogen receptor modulators. Horm Res 1997, 48:155-163.
2. Sato M, Rippy MK, Bryant HU: Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonproductive tissues in ovariectomized rats. FASEB J 1996, 10:905-912.
3. Korach KS, Couse JF, Curtis SW, Washburn TF, Lindzey J, Kimbro KS, Eddy EM, Migliaccio S, Snedeker SM, Lubahn DB et al.: Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes. Recent Progr Horm Res 1996, 51:159-186.
4. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson J-A: Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996, 93:5925-5930.
5. •], are collectors' items, since they all provide original information on the phenotype of ERLP mice.
6. •], are collectors' items, since they all provide original information on the phenotype of ERLP mice.
7. •], are collectors' items, since they all provide original information on the phenotype of ERLP mice.
8. Couse JF, Lindzey J, Grandien K, Gustafsson J-ü, Korach KS: Tissue distribution and quantitative analysis of estrogen receptor-alpha (ER-alpha) and estrogen receptor-beta (ER-beta) messenger ribonucleic acid in the wild-type and ER-alpha-knockout mouse. Endocrinology 1997, 138:4613-4621.
9. Shughrue PJ, Lubahn DB, Negro-Vilar A, Korach KS, Merchenthaler I: Responses in the brain of estrogen receptor alpha-disrupted mice. Proc Natl Acad Sci USA 1997, 94:11008-11012. This paper is a uniquely original and important study showing not only that estrogen receptor α is important in the male reproductive system but also providing a mechanism through which estradiol affects male fertility.
10. Iafrati MD, Karas RH, Aronovitz M, Kim S, Sullivan TR Jr, Lubahn DB, O'Donnell TF Jr, Korach KS, Mendelsohn ME: Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice. Nat Med 1997, 3:545-548. This is a very thought provoking and important paper revealing estogen effects in the coromary arteries in estrogen receptor (ER) knockout mice and thus suggesting a function for ERβ in the vascular system.
11. Sudhir K, Chou TM, Chatterjee K, Smith EP, Williams TC, Kane JP, Malloy MJ, Korach KS, Rubanyi GM: Premature coronary artery disease associated with a disruptive mutation in the estrogen receptor gene in a man. Circulation 1997, 96:3774-3777.
12. Kuiper GGLM, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson J-A: Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997, 138:863-870. This paper provides important and useful information for those interested in specific ligands for the two estrogen receptors. In vitro translated receptors were used for binding studies with a series of steroids and their metabolites, phytoestrogens and xenoestrogens.
13. Sundin M, Warner M, Haaparanta T, Gustafsson J-A: Isolation and catalytic activity of cytochrome P450 from ventral prostate of control rats. J Biol Chem 1987, 262:12293-12297.
14. Warner M, Strömstedt M, Möller L, Gustafsson J-Å: Distribution and regulation of 5α-androstane-3β,17β-diol hydroxylase in the rat central nervous system. Endocrinology 1989, 124:2699-2706.
15. Brzozowski AM, Pike ACW, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson J-Å, Carlquist M: Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 1997, 389:753-758. Truly a landmark paper revealing structural differences in the ligand binding domain of estrogen receptor α in the presence of agonist and antagonist.
16. Paech K, Webb P, Kuiper GGJM, Nilsson S, Gustafsson J-Å, Kushner PJ, Scanlan TS: Differential ligand activation of estrogen receptors ER-alpha and ER-beta at AP-1 sites Science 1997, 277:1508-1510. This is a very important paper showing for the first time that estrogen receptor (ER)a and ERβ have opposite effects at the AP-1 site.
17. Montano MM, Katzenellenbogen BS: The quinone reductase gene: a unique estrogen receptor-regulated gene that is activated by antiestrogens. Proc Natl Acad Sci USA 1997, 94:2581-2586. The authors of this paper reveal that quinone reductase is an important marker gene which is upregulated by tamoxifen. It may be extremely useful in distinguishing estrogen receptor (ER)α and ERβ effects in vivo.
18. Delmas PD, Bjarnason NH, Mitlak BH, Ravoux AC, Shah AS, Huster WJ, Draper M, Christiansen C: Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. New Engl J Med 1997, 337:1641-1647. This paper makes important reading for those following the clinical effects of long term use of anti-estrogens.
19. Reginster JY, Bufalino L, Christiansen C, Devogelaer JP, Gennari C, Riis BJ, Roux C: Design for an ipriflavone multicenter European fracture study. Calc Tiss Int 1997, 61:828-32. This paper makes important reading for those interested in the clinical use of ipriflavone as an alternative to hormone replacement therapy in the postmenopausal female.
20. Yamaguchi M, Gao YH: Inhibitory effect of genistein on bone resorption in tissue culture. Biochem Pharmacol 1998, 55:71-76.
21. Dodge JA, Glasebrook AL, Magee DE: Phillips DL, Sato M, Short LL, Bryant HU: Environmental estrogens: effects on cholesterol lowering and bone in the ovariectomized rat. J Steroid Biochem Mol Biol 1996, 59:155-161.
22. Petilli M, Fiorelli G: Benvenuti S, Frediani U, Gori F, Brandi ML: Interactions between ipriflavone and the estrogen receptor. Calc Tiss Int 1995, 56:160-165.
23. Gehm BD, McAndrews JM, Chien PY, Jameson JL: Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci USA 1997, 94:14138-14143.
24. Fisch H, Andrews H, Hendricks J, Goluboff ET, Olson JH, Olsson CA: The relationship of sperm counts to birth rates: a population based study. J Urol 1997, 157:840-843.
25. Safe SH: Environmental and dietary estrogens and human health: is there a problem? Environ Health Perspect 1995, 103:346-351.
26. Kuiper GG, Gustafsson J-A: The novel estrogen receptor-beta subtype: potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens. FEBS Lett 1997, 410:87-90.
27. Benediktsson R, Walker BR, Edwards CR: Cellular selectivity of aldosterone action: role of 11 beta-hydroxysteroid dehydrogenase. Curr Opin Nephrol Hyperten 1995, 4:41-46.